Key result
More thrombectomy passes in medium vessel occlusion linked to ~30% lower odds of favorable 90-day mRS.
Why the study?
First-pass reperfusion is associated with favorable outcomes after mechanical thrombectomy for medium vessel occlusion, but the impact of an increasing number of thrombectomy passes remained unclear.
Does an increasing number of thrombectomy passes affect 90-day modified Rankin Scale outcomes and symptomatic intracranial hemorrhage risk in patients undergoing mechanical thrombectomy for medium vessel occlusion?
Observational (n=234)
Yes
Does an increasing number of thrombectomy passes affect 90-day modified Rankin Scale outcomes and symptomatic intracranial hemorrhage risk in patients undergoing mechanical thrombectomy for medium vessel occlusion?
In patients undergoing mechanical thrombectomy for medium vessel occlusion, an increasing number of passes (especially ≥3 passes) is associated with worse 90-day functional outcomes and increased risk of symptomatic intracranial hemorrhage, supporting caution with additional passes.
May warrant caution with multiple passes in medium vessel occlusion; leaves open causality and optimal strategy pending trials.
Background First-pass reperfusion is associated with favorable outcomes after mechanical thrombectomy (MT) for medium vessel occlusion (MeVO), but the impact of increasing pass number remains unclear. We investigated the association between thrombectomy pass number and outcomes in MeVO. Methods Patients undergoing MT for MeVO between January 2016 and December 2025 were retrospectively analyzed in a multicenter registry. The primary outcome was the 90-day modified Rankin Scale (mRS) distribution. Multivariable models evaluated associations between pass number and outcomes, adjusting for first-line thrombectomy procedure and subsequently for treatment timing, procedure duration, excellent reperfusion, and symptomatic intracranial hemorrhage (sICH). Exploratory threshold and marginal effects analyses were performed. Results Among 234 patients, 111, 58, 31, and 34 underwent 1, 2, 3, and ≥4 passes, respectively. Increasing pass number was associated with a less favorable 90-day mRS distribution (adjusted common OR 0.70 (95% CI 0.58 to 0.85)) and a higher risk of sICH (adjusted OR 1.64 (95% CI 1.07 to 2.54)). The association with 90-day mRS remained significant after additional adjustment for onset-to-puncture time, puncture-to-procedure end time, and excellent reperfusion (adjusted common OR 0.73 (95% CI 0.58 to 0.94)). In exploratory threshold analyses, ≥3 passes was the first prespecified cut-off associated with both lower functional independence and increased sICH, while adjusted functional independence declined progressively with increasing pass number. Conclusions Increasing pass number was associated with less favorable functional outcomes and a higher sICH risk after MT for MeVO. These findings do not establish a stopping rule but support caution with additional passes.
No takes yet. Share an insight, caveat, or question.
Namitome et al. (2026) conducted an observational in Medium vessel occlusion undergoing mechanical thrombectomy (n=234). Increasing number of thrombectomy passes vs. Fewer thrombectomy passes (1, 2, 3, vs ≥4 passes) was evaluated on 90-day modified Rankin Scale (mRS) distribution (adjusted common OR 0.70, 95% CI 0.58-0.85). Increasing thrombectomy pass number in medium vessel occlusion was associated with a less favorable 90-day mRS distribution (adjusted common OR 0.70; 95% CI 0.58-0.85).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: